Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo T Calado

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Annals of Hematology|July 7, 2018
Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective studyDiego V Clé, Elias H Atta, Danielle S P Dias, et al.
British Journal of Haematology|July 11, 2012
High frequency of copy number alterations in myeloid leukaemia of Down syndromeMarjolein Blink, Marry M van den Heuvel-Eibrink, Anna M Aalbers, et al.
Lancet Regional Health. Americas|March 21, 2022
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma <i>versus</i> standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)Alice T W Song, Vanderson Rocha, Alfredo Mendrone-Júnior, et al.
International Journal of Molecular Sciences|August 12, 2023
BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association StudyBruna C Bertol, Juliana D Massaro, Guilherme Debortoli, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyDimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Blood Advances|April 1, 2026
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic AnemiaPhillip Scheinberg, Debra A O'Neal, Ana Lisa Basquiera, et al.
Blood|April 13, 2023
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuriaCarmelo Gurnari, Pedro Henrique Prata, Luiz Fernando B Catto, et al.
Blood Advances|September 29, 2023
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemiaLuiz Fernando B Catto, Leonardo C Zanelatto, Flavia S Donaires, et al.
Vaccine|March 4, 2025
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in BrazilÉrique José Farias Peixoto de Miranda, Rodrigo T Calado, Fernanda Castro Boulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2022
Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCarmelo Gurnari, Simona Pagliuca, Pedro Henrique Prata, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Annals of Hematology|July 7, 2018
Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective studyDiego V Clé, Elias H Atta, Danielle S P Dias, et al.
British Journal of Haematology|July 11, 2012
High frequency of copy number alterations in myeloid leukaemia of Down syndromeMarjolein Blink, Marry M van den Heuvel-Eibrink, Anna M Aalbers, et al.
Lancet Regional Health. Americas|March 21, 2022
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma <i>versus</i> standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI)Alice T W Song, Vanderson Rocha, Alfredo Mendrone-Júnior, et al.
International Journal of Molecular Sciences|August 12, 2023
BRAF, TERT and HLA-G Status in the Papillary Thyroid Carcinoma: A Clinicopathological Association StudyBruna C Bertol, Juliana D Massaro, Guilherme Debortoli, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacyDimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Blood Advances|April 1, 2026
American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic AnemiaPhillip Scheinberg, Debra A O'Neal, Ana Lisa Basquiera, et al.
Blood|April 13, 2023
IPSS-M in myelodysplastic neoplasms arising from aplastic anemia and paroxysmal nocturnal hemoglobinuriaCarmelo Gurnari, Pedro Henrique Prata, Luiz Fernando B Catto, et al.
Blood Advances|September 29, 2023
Telomeric repeat-containing RNA is dysregulated in acute myeloid leukemiaLuiz Fernando B Catto, Leonardo C Zanelatto, Flavia S Donaires, et al.
Vaccine|March 4, 2025
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Results of a randomized vaccine-controlled phase I ADAPTCOV trial in BrazilÉrique José Farias Peixoto de Miranda, Rodrigo T Calado, Fernanda Castro Boulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2022
Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal HemoglobinuriaCarmelo Gurnari, Simona Pagliuca, Pedro Henrique Prata, et al.
Pageof 15